16 found
Order:
  1.  21
    Flattening the Rationing Curve: The Need for Explicit Guidelines for Implicit Rationing during the COVID-19 Pandemic.Kayte Spector-Bagdady, Naomi Laventhal, Megan Applewhite, Janice I. Firn, Norman D. Hogikyan, Reshma Jagsi, Adam Marks, Renee McLeod-Sordjan, Lisa S. Parker, Lauren B. Smith, Christian J. Vercler & Andrew G. Shuman - 2020 - American Journal of Bioethics 20 (7):77-80.
    Volume 20, Issue 7, July 2020, Page 77-80.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  2.  19
    The Inherent Unfairness of COVID-19 Drug Access Pathways.Kayte Spector-Bagdady, Misty Gravelin, Kevin J. Weatherwax & Andrew G. Shuman - 2020 - American Journal of Bioethics 20 (9):18-20.
    Volume 20, Issue 9, September 2020, Page 18-20.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  3.  16
    Rethinking the Importance of the Individual within a Community of Data.Kayte Spector-Bagdady & Jonathan Beever - 2020 - Hastings Center Report 50 (4):9-11.
    The Covid‐19 crisis has underscored the importance of the collection and analysis of clinical and research data and specimens for ongoing work. The federal government recently completed a related revision of the human subjects research regulations, founded in the traditional principles of research ethics, but in this commentary, we argue that the analysis underpinning this revision overemphasized the importance of informed consent, given the low risks of secondary research. Governing the interests of a community is different from governing the interests (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  4.  19
    The Critical Role of Medical Institutions in Expanding Access to Investigational Interventions.Kayte Spector-Bagdady, Kevin J. Weatherwax, Misty Gravelin & Andrew G. Shuman - 2019 - Hastings Center Report 49 (2):36-39.
    The U.S. federal government provides two tracks for eligible patients to obtain access outside clinical trials to investigational interventions currently under study for potential clinical benefits: the Food and Drug Administration’s expanded access pathway and the pathway created by the more recent Right to Try Act. In this issue of the Hastings Center Report, with a critical focus on patients, industry, and the research enterprise, Kelly Folkers and colleagues frame the inherent challenges that these pathways are meant to solve and (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  5.  26
    Allocation of Opportunities to Participate in Clinical Trials during the Covid‐19 Pandemic and Other Public Health Emergencies.Kayte Spector-Bagdady, Holly Fernandez Lynch, Barbara E. Bierer, Luke Gelinas, Sara Chandros Hull, David Magnus, Michelle N. Meyer, Richard R. Sharp, Jeremy Sugarman, Benjamin S. Wilfond, Ruqaiijah Yearby & Seema Mohapatra - 2021 - Hastings Center Report 52 (1):51-58.
    Hastings Center Report, Volume 52, Issue 1, Page 51-58, January/February 2022.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  6.  18
    Stemming the Standard‐of‐Care Sprawl.Kayte Spector-Bagdady, Raymond De Vries, Lisa Hope Harris & Lisa Kane Low - 2017 - Hastings Center Report 47 (6):16-24.
    The “best interests of the patient” standard—a complex balance between the principles of beneficence and autonomy—is the driving force of ethical clinical care. Clinicians’ fear of litigation is a challenge to that ethical paradigm. But is it ever ethically appropriate for clinicians to undertake a procedure with the primary goal of protecting themselves from potential legal action? Complicating that question is the fact that tort liability is adjudicated based on what most clinicians are doing, not the scientific basis of whether (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  7.  44
    Stemming the Standard‐of‐Care Sprawl.Kayte Spector-Bagdady, Raymond Vries, Lisa Hope Harris & Lisa Kane Low - 2017 - Hastings Center Report 47 (6):16-24.
    The “best interests of the patient” standard—a complex balance between the principles of beneficence and autonomy—is the driving force of ethical clinical care. Clinicians’ fear of litigation is a challenge to that ethical paradigm. But is it ever ethically appropriate for clinicians to undertake a procedure with the primary goal of protecting themselves from potential legal action? Complicating that question is the fact that tort liability is adjudicated based on what most clinicians are doing, not the scientific basis of whether (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  8.  16
    Generative-AI-Generated Challenges for Health Data Research.Kayte Spector-Bagdady - 2023 - American Journal of Bioethics 23 (10):1-5.
    Generative artificial intelligence (GenAI) promises to revolutionize data-driven fields (Milmo 2023). Building on decades of large language modeling (LLM) (Toner 2023), GenAI can collect, harmonize...
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  9.  21
    Present Lessons from Past Infractions.Karen M. Meagher & Kayte Spector-Bagdady - 2014 - Teaching Ethics 14 (2):53-76.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  10.  6
    “Consent Does Not Scale”: Laying Out the Tensions in Balancing Patient Autonomy with Public Benefit in Commercializing Biospecimens.Kayte Spector-Bagdady - 2023 - Journal of Law, Medicine and Ethics 51 (2):437-439.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  11. Improving commercial genetic data-sharing policy.Kayte Spector-Bagdady - 2021 - In I. Glenn Cohen, Nita A. Farahany, Henry T. Greely & Carmel Shachar (eds.), Consumer genetic technologies: ethical and legal considerations. New York, NY: Cambridge University Press.
     
    Export citation  
     
    Bookmark  
  12.  18
    Promoting Ethical Deployment of Artificial Intelligence and Machine Learning in Healthcare.Kayte Spector-Bagdady, Vasiliki Rahimzadeh, Kaitlyn Jaffe & Jonathan Moreno - 2022 - American Journal of Bioethics 22 (5):4-7.
    The ethics of artificial intelligence and machine learning exemplify the conceptual struggle between applying familiar pathways of ethical analysis versus generating novel strategies. Mel...
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  13.  16
    Public Health Service Research in Guatemala: Toward New Scholarship.Kayte Spector-Bagdady - 2013 - Hastings Center Report 43 (4):3-3.
    A commentary on “‘Ever Vigilant’ in ‘Ethically Impossible’: Structural Injustice and Responsibility in PHS Research in Guatemala,” from the May‐June 2013 issue.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  14.  23
    “Something of an Adventure”: Postwar NIH Research Ethos and the Guatemala STD Experiments.Kayte Spector-Bagdady & Paul A. Lombardo - 2013 - Journal of Law, Medicine and Ethics 41 (3):697-710.
    The STD experiments in Guatemala from 1946–1948 have earned a place of infamy in the history of medical ethics. But if the Guatemala STD experiments were so “ethically impossible,” how did the U.S. government approve their funding? Although much of the literature has targeted the failings of Dr. John Cutler, we focus on the institutional context and research ethos that shaped the outcome of the research. After the end of WWII, Dr. Cassius Van Slyke reconstructed the federal research contracts process (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  15.  14
    “Something of an Adventure”: Postwar NIH Research Ethos and the Guatemala STD Experiments.Kayte Spector-Bagdady & Paul A. Lombardo - 2013 - Journal of Law, Medicine and Ethics 41 (3):697-710.
    Since their revelation to the public, the sexually transmitted disease experiments in Guatemala from 1946 to 1948 have earned a place of infamy in the history of medical ethics. During these experiments, Public Health Service researchers intentionally exposed over 1,300 non-consenting Guatemalan soldiers, prisoners, psychiatric patients, and commercial sex workers to gonorrhea, syphilis, and/or chancroid under conditions that have shocked the medical community and public alike. Expert analysis has found little scientific value to the experiments as measured by current or (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  16.  5
    Translating Commercial Health Data Privacy Ethics into Change.Kayte Spector-Bagdady & I. I. W. Nicholson Price - 2023 - American Journal of Bioethics 23 (11):7-10.
    Hundreds of articles have been written over the past several decades delineating the ethical tensions of health data commercialization, empirically querying the preferences of data contributors, an...
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark